Last reviewed · How we verify
NCT06947213
Orthorexia Nervosa in Postmenopausal Osteoporosis
trial in Osteoporosis in 128 participants. Currently enrolling.
20 May 2025
Quick facts
| Lead sponsor | Beylikduzu State Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 128 |
| Start date | 20 April 2025 |
| Primary completion | 20 May 2025 |
| Estimated completion | 20 May 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Osteoporosis — all drugs for Osteoporosis →
Sponsor
Beylikduzu State Hospital
Who can join
Adults 55 to 75, female only, with Osteoporosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A total of 64 female patients diagnosed with osteoporosis based on dual-energy X-ray absorptiometry (DXA) measurements performed within the last six months, and 64 age-matched healthy controls without osteoporosis, will be included in our study. Sociodemographic data such as age, sex, height, weight, and BMI will be recorded. Additionally, information regarding the duration of osteoporosis diagnosis, current treatments, history of fractures, history of falls, comorbidities, and smoking status will be collected. Femoral neck and L1-L4 T-scores and bone mineral density values obtained from existing DXA scans will be documented. Orthorexia nervosa-related symptoms will be assessed using the ORTO-11 scale, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and body image will be assessed using the Body Appreciation Scale-2.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06947213
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteoporosis
Currently open trials in the same condition.
- NCT07027306 — The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fract · recruiting
- NCT07367776 — Patient Education in Osteoporosis (RCT-PATOS) · NA · recruiting
- NCT06731608 — OsteoPorotic fracTure preventION System (OPTIONS) Research Study · NA · recruiting
- NCT07281586 — Step-down Therapy After Long-term Osteoporosis Treatment · Phase 4 · recruiting
- NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
Other Beylikduzu State Hospital trials
Trials by the same sponsor.
- NCT07044999 — Evaluation of Balance and Physical Performance Under Dual Task Conditions in Individuals With and Without Generalized Jo · not yet recruiting
- NCT07044986 — Ultrasonographic Evaluation of the Ulnar Nerve in Individuals With and Without Generalized Joint Hypermobility · not yet recruiting
- NCT07045012 — The Relationship Between Osteoporosis and Sarcopenia Parameters in Postmenopausal Women Under 60 · not yet recruiting
- NCT06947200 — Orthorexia Nervosa in Fibromyalgia · recruiting
- NCT07238777 — MRI-Based Paraspinal Fatty Degeneration and Its Association With BMD and Sarcopenia · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06947213 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beylikduzu State Hospital
- Last refreshed: 27 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06947213.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing